SI News & Events

Reports Q4 revenue $14.4M, consensus $12.79M. "2025 was a transformational year for Shoulder Innovations. We continued to add new surgeon customers at an accelerated pace, drove rapid commercial adoption of our advanced implant systems, and solidified our position as an innovation leader in the shoulder space, all while beginning our journey as a public company," said Rob Ball, CEO of Shoulder Innovations. "These efforts culminated in record full-year net revenue of $47.3M, representing an exceptional 50% increase year-over-year, supported by accelerating growth in the second half of the year."

FY26 revenue view represents a growth of 31%-37% vs. FY25. Rob Ball, CEO of Shoulder Innovations said, "Looking into 2026, our momentum remains strong. Our key strategic priorities are focused on delivering sustained growth through world class execution and innovation. With a growing product portfolio, a comprehensive enabling technology strategy, our expanding commercial talent, and a strong balance sheet, we believe we are well positioned to further extend and strengthen our leadership position in shoulder surgical care in the years ahead."